eWellness Healthcare(EWLL)
$0.000.00 (0.00%)
EWLL
eWellness Healthcare financials statements
$0.00
At close:0.00 (0.00%)
eWellness Healthcare (EWLL) Ratios
60 Followers
eWellness Healthcare Ratios
EWLL's free cash flow for Q1 2022 was $-45.31K. For the 2022 fiscal year, EWLL's free cash flow was increased by $0.00 and operating cash flow was $-45.31K. See a summary of the company’s cash flow.
| Ratios | Dec 21 | Dec 20 | Dec 19 | Dec 18 | Dec 17 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.00 | 0.00 | 0.05 | 0.11 | 0.05 |
| Quick Ratio | 0.00 | 0.00 | 0.05 | 0.11 | 0.05 |
| Cash Ratio | 0.00 | 0.00 | 0.03 | 0.09 | 0.00 |
| Solvency Ratio | -0.16 | -1.32 | -1.29 | -0.99 | -0.27 |
| Operating Cash Flow Ratio | -0.08 | -0.04 | -0.41 | -0.29 | -0.25 |
| Short-Term Operating Cash Flow Coverage | -0.25 | -0.21 | -1.33 | -2.29 | -1.52 |
| Net Current Asset Value | $ -4.36M | $ -6.66M | $ -6.94M | $ -4.01M | $ -3.65M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 100.01 | 166.61 | 5.17 | 1.12 | 3.04 |
| Debt-to-Equity Ratio | -0.31 | -0.20 | -0.32 | -0.14 | -0.17 |
| Debt-to-Capital Ratio | -0.45 | -0.26 | -0.48 | -0.16 | -0.21 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.00 | -0.00 | -0.06 | -0.13 | -0.06 |
| Debt Service Coverage Ratio | -1.65 | -3.38 | -0.73 | -2.82 | -2.94 |
| Interest Coverage Ratio | -10.32 | -2.51 | -0.95 | -4.96 | -6.49 |
| Debt to Market Cap | 0.39 | 0.86 | 8.82 | 0.02 | 0.05 |
| Interest Debt Per Share | 0.00 | 0.00 | 1.33 | 0.39 | 0.52 |
| Net Debt to EBITDA | -0.50 | -0.17 | -0.41 | -0.05 | -0.18 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 95.79% | 100.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | -2932.44% | -135680.88% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | -2929.81% | -135488.31% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | -897.33% | -118321.87% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | -3290.69% | -260220.08% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | -3290.69% | -260275.10% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | -3290.69% | -260275.10% | 0.00% | 0.00% |
| Net Income Per EBT | 157.08% | 100.00% | 100.02% | 100.02% | 100.10% |
| EBT Per EBIT | 16.92% | 366.72% | 219.93% | 120.43% | 30.82% |
| Return on Assets (ROA) | -5234.44% | -107870.14% | -2183.45% | -883.25% | -502.23% |
| Return on Equity (ROE) | 16.29% | 131.78% | 137.00% | 111.81% | 28.46% |
| Return on Capital Employed (ROCE) | 61.29% | 35.93% | 62.28% | 92.82% | 92.28% |
| Return on Invested Capital (ROIC) | 89.00% | 45.12% | 92.18% | 108.08% | 111.46% |
| Return on Tangible Assets | -5234.44% | -107870.14% | -2229.76% | -902.96% | -538.78% |
| Earnings Yield | -20.19% | -558.78% | -3722.60% | -13.05% | -7.65% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 70.37 | 0.16 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 32.78 | 0.01 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | -0.04 | -0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -318471.09 | -29012.82 | 365.00 | -56190.84 | -49692.65 |
| Days of Sales Outstanding | 0.00 | 0.00 | 365.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 318471.09 | 29012.82 | 0.00 | 56190.84 | 49692.65 |
| Operating Cycle | 0.00 | 0.00 | 365.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.59 | -0.38 | -0.44 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.59 | -0.39 | -0.44 |
| Dividend Paid and CapEx Coverage Ratio | -85398.50 | -94871.00 | -221.49 | -90.51 | -326.84 |
| Capital Expenditure Coverage Ratio | -85398.50 | -94871.00 | -221.49 | -90.51 | -326.84 |
| Operating Cash Flow Coverage Ratio | -0.25 | -0.21 | -1.33 | -2.29 | -1.52 |
| Operating Cash Flow to Sales Ratio | 0.00 | -1.07 | -819.48 | 0.00 | 0.00 |
| Free Cash Flow Yield | -9.72% | -18.13% | -1177.36% | -3.82% | -7.07% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.95 | -0.18 | -0.03 | -7.66 | -13.07 |
| Price-to-Sales (P/S) Ratio | 0.00 | 5.89 | 69.92 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -0.81 | -0.24 | -0.04 | -8.57 | -3.72 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -10.29 | -5.52 | -0.08 | -26.19 | -14.15 |
| Price-to-Operating Cash Flow Ratio | -10.29 | -5.52 | -0.09 | -26.48 | -14.19 |
| Price-to-Earnings Growth (PEG) Ratio | 0.05 | 0.00 | -0.00 | -0.04 | 0.13 |
| Enterprise Value Multiple | -1.82 | -0.37 | -0.46 | -9.29 | -4.21 |
| Enterprise Value | 4.86M | 2.92M | 2.25M | 34.29M | 14.12M |
| EV to EBITDA | -1.82 | -0.37 | -0.46 | -9.29 | -4.21 |
| EV to Sales | 0.00 | 10.97 | 620.04 | 0.00 | 0.00 |
| EV to Free Cash Flow | -14.23 | -10.27 | -0.75 | -26.33 | -14.80 |
| EV to Operating Cash Flow | -14.23 | -10.27 | -0.76 | -26.62 | -14.84 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -1.36 | -1.18 | -1.67 |
| Shareholders’ Equity Per Share | -0.00 | -0.00 | -1.36 | -1.18 | -1.67 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | -1.86 | -1.32 | -0.47 |
| Tax Burden | 1.57 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.17 | 1.12 | 1.92 | 1.20 | 0.31 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 9.93 | 1184.32 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.76 | 0.03 | 0.31 | 0.29 | 0.92 |
Currency in USD
